Radiopaedia.org 2015
DOI: 10.53347/rid-41676
|View full text |Cite
|
Sign up to set email alerts
|

Idiopathic intracranial hypertension

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Final visual outcomes are usually similar between typical and atypical presentations, but visual field loss at presentation plays a crucial role in predicting the prognosis of visual outcomes in all patients [8]. There are no specific protocols or guidelines for the management of IIH; however, it is concluded that acetazolamide is effective and safe for IIH treatment and that the benefits of acetazolamide can be seen within the first 4-6 weeks of therapy [9,[13][14][15]. Some physicians do keep patients on acetazolamide for a few months before tapering off the dose despite seeing good results early on [15].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Final visual outcomes are usually similar between typical and atypical presentations, but visual field loss at presentation plays a crucial role in predicting the prognosis of visual outcomes in all patients [8]. There are no specific protocols or guidelines for the management of IIH; however, it is concluded that acetazolamide is effective and safe for IIH treatment and that the benefits of acetazolamide can be seen within the first 4-6 weeks of therapy [9,[13][14][15]. Some physicians do keep patients on acetazolamide for a few months before tapering off the dose despite seeing good results early on [15].…”
Section: Discussionmentioning
confidence: 99%
“…There are no specific protocols or guidelines for the management of IIH; however, it is concluded that acetazolamide is effective and safe for IIH treatment and that the benefits of acetazolamide can be seen within the first 4-6 weeks of therapy [9,[13][14][15]. Some physicians do keep patients on acetazolamide for a few months before tapering off the dose despite seeing good results early on [15].…”
Section: Discussionmentioning
confidence: 99%